Citeline Podcasts

Profusa Inc. has big plans for its tiny, injectable biosensors, a novel monitoring technology designed to be place under the skin for detecting and measuring body chemistry. In an exclusive podcast interview with Medtech Insight, Profusa's Chairman and CEO Ben Hwang talked about the technology, the upcoming market launch, and what's next for the company.

Scott Danzis and Mark Young, attorneys with Covington and Burling, discuss FDA and the EU's efforts surrounding medical device cyber security. While the experts note American regulators are ahead in terms of providing specific guidances on the topic, the Europeans are in theory in-step with their cousins across the pond.

Profusa Inc. has big plans for its tiny, injectable biosensors, a novel monitoring technology designed to be place under the skin for detecting and measuring body chemistry. In an exclusive podcast interview with Medtech Insight, Profusa's Chairman and CEO Ben Hwang talked about the technology, the upcoming market launch, and what's next for the company.

Scott Danzis and Mark Young, attorneys with Covington and Burling, discuss FDA and the EU's efforts surrounding medical device cyber security. While the experts note American regulators are ahead in terms of providing specific guidances on the topic, the Europeans are in theory in-step with their cousins across the pond.

Profusa Inc. has big plans for its tiny, injectable biosensors, a novel monitoring technology designed to be place under the skin for detecting and measuring body chemistry. In an exclusive podcast interview with Medtech Insight, Profusa's Chairman and CEO Ben Hwang talked about the technology, the upcoming market launch, and what's next for the company.

On this week's podcast, Clinica's Amanda Maxwell discusses what's new in the European Union, including what the UK’s potential exit from the EU means for device regulations. Also, the latest on Europe's medical device and diagnostic reform efforts and the growing strain on notified bodies.

On this week's podcast, Clinica's Amanda Maxwell discusses what's new in the European Union, including what the UK’s potential exit from the EU means for device regulations. Also, the latest on Europe's medical device and diagnostic reform efforts and the growing strain on notified bodies.

On this week's podcast, Clinica's Amanda Maxwell discusses what's new in the European Union, including what the UK’s potential exit from the EU means for device regulations. Also, the latest on Europe's medical device and diagnostic reform efforts and the growing strain on notified bodies.

On this week's podcast, the team discusses the confirmation of Robert Califf as FDA commissioner and his priorities, the president's Precision Medicine Initiative at the White House, the long-awaited release of the new global quality standard for medical devices, unannounced audits in Europe, device firms at the Supreme Court, an interesting deal for ResMed and more.

On this week's podcast, the team discusses the confirmation of Robert Califf as FDA commissioner and his priorities, the president's Precision Medicine Initiative at the White House, the long-awaited release of the new global quality standard for medical devices, unannounced audits in Europe, device firms at the Supreme Court, an interesting deal for ResMed and more.